These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21478748)

  • 1. Dehydroepiandrosterone sulfate and postmenopausal women.
    Goel RM; Cappola AR
    Curr Opin Endocrinol Diabetes Obes; 2011 Jun; 18(3):171-6. PubMed ID: 21478748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal DHEA to treat menopause related atrophy: a review of the evidence.
    Panjari M; Davis SR
    Maturitas; 2011 Sep; 70(1):22-5. PubMed ID: 21733647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dehydroepiandrosterone (DHEA) and the menopause: an update.
    Raven PW; Hinson JP
    Menopause Int; 2007 Jun; 13(2):75-8. PubMed ID: 17540138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dhea supplementation and cognition in postmenopausal women.
    Parsons TD; Kratz KM; Thompson E; Stanczyk FZ; Buckwalter JG
    Int J Neurosci; 2006 Feb; 116(2):141-55. PubMed ID: 16393880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women.
    Labrie F; Cusan L; Gomez JL; Côté I; Bérubé R; Bélanger P; Martel C; Labrie C
    J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):178-94. PubMed ID: 18598765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DHEA, important source of sex steroids in men and even more in women.
    Labrie F
    Prog Brain Res; 2010; 182():97-148. PubMed ID: 20541662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration.
    Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Bérubé R; Bélanger P; Berger L; Gilbert L; Martel C; Balser J
    Menopause; 2009; 16(5):897-906. PubMed ID: 19436226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DHEA for postmenopausal women: a review of the evidence.
    Panjari M; Davis SR
    Maturitas; 2010 Jun; 66(2):172-9. PubMed ID: 20089375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Dehydroepiandrosterone And WellNess (DAWN) study: research design and methods.
    von Mühlen D; Laughlin GA; Kritz-Silverstein D; Barrett-Connor E
    Contemp Clin Trials; 2007 Feb; 28(2):153-68. PubMed ID: 16784898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women.
    Dorgan JF; Stanczyk FZ; Longcope C; Stephenson HE; Chang L; Miller R; Franz C; Falk RT; Kahle L
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):177-81. PubMed ID: 9138660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dehydroepiandrosterone supplementation on cognitive function and activities of daily living in older women with mild to moderate cognitive impairment.
    Yamada S; Akishita M; Fukai S; Ogawa S; Yamaguchi K; Matsuyama J; Kozaki K; Toba K; Ouchi Y
    Geriatr Gerontol Int; 2010 Oct; 10(4):280-7. PubMed ID: 20497239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of dehydroepiandrosterone in postmenopausal women with fibromyalgia.
    Finckh A; Berner IC; Aubry-Rozier B; So AK
    J Rheumatol; 2005 Jul; 32(7):1336-40. PubMed ID: 15996074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women.
    Genazzani AR; Pluchino N; Begliuomini S; Stomati M; Bernardi F; Pieri M; Casarosa E; Palumbo M; Genazzani AD; Luisi M
    Gynecol Endocrinol; 2006 Nov; 22(11):627-35. PubMed ID: 17145649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associated hormonal declines in aging: DHEAS.
    Perrini S; Laviola L; Natalicchio A; Giorgino F
    J Endocrinol Invest; 2005; 28(3 Suppl):85-93. PubMed ID: 16042365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DHEA replacement for postmenopausal women: placebo or panacea?
    Eden JA
    Climacteric; 2015; 18(4):439-40. PubMed ID: 25731680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women.
    Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
    Menopause; 2009; 16(5):923-31. PubMed ID: 19424093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DHEA therapy in postmenopausal women: the need to move forward beyond the lack of evidence.
    Genazzani AR; Pluchino N
    Climacteric; 2010 Aug; 13(4):314-6. PubMed ID: 20540592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy.
    Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
    Menopause; 2009; 16(5):907-22. PubMed ID: 19436225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dehydroepiandrosterone (DHEA)--structure, clinical importance and the role in human body].
    Zdrojewicz Z; Ciszko B
    Postepy Hig Med Dosw; 2001; 55(6):835-54. PubMed ID: 11875781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.